Product Images Riabni

This appears to be a data chart showing the percentage of ACR 20 responders for a medication called Rituximab at 20 and 24 weeks. The medication was administered at a dose of 2x1000mg. However, the chart is incomplete and it's not possible to determine what the percentage values actually represent.*

This appears to be a table showing data on subjects and their use of various drugs, namely Azathioprine and Rituximab. The table shows the number of people experiencing major relapse survival time (in months) with each drug, as well as the number of subjects at risk. There are also some numbers that are difficult to interpret, such as "100" and "2w". Overall, it is difficult to provide a more specific description without additional context.*

This is a product description for a single-dose vial of Rituximab-arrx with 100mg/10mL (10mg/mL) meant for intravenous infusion after dilution. It should be stored refrigerated at 2°C to 8°C (36°F to 46°F) and should be protected from direct sunlight. This is a sterile solution with no preservative. The enclosed medication guide is required for each patient.*

This is a description of a medication called "RIABNI" with the NDC (National Drug Code) number 55513326801, which is a single-dose of Val (rituximab-arx) meant for intravenous use only. The unused portion should be discarded. It comes in a 500 mg/50 mL (10mg/mL) container and should be stored in a refrigerator at a temperature between 2°C to 8°C (36°F to 46°F). It must be protected from direct sunlight, not frozen, and not shaken. The medication does not have any preservative. An enclosed medication guide is required for each patient.*